Five years after his first pass, the AD100 designer reimagines the same home as a serene, wood-clad retreat for a Manhattan ...
AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
Wearable technology developer Biolinq has won FDA authorisation for a biosensor that can measure glucose levels continuously just beneath the skin's surface, without the need for a needle. The San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback